Ron van Schaik
机构: Professor Pharmacogenetics, Erasmus
每年引用次数
引用次数
引用: 28,042
H-指数: 84
I10-指数 : 322
出版物: 733
Variabiliteit in fenotypische O-demethylatie activiteit bij de jonge zuigeling: leeftijd en erfelijkheid!
Christine Vanhole , Karel Allegaert , René Verbesselt , Veerle Cossey
Tijdschrift Voor Kindergeneeskunde ( 111)
2007
Clinical implementation of cardiovascular pharmacogenetics: Where are we?
van Schaik R.H.N.
Clinical Biochemistry 46 ( 12) 1148
2013
Detection limit, cut-off and specificity of an improved rapid assay for cardiac troponin T.
Zerback R , Bertsch T , Nagel D , Luz H
Clinical Laboratory 47 549
1
2001
Te vroeg voor farmacogenetica in de psychiatrische praktijk? : Implementatie is volop gaande
R H N van Schaik , P M Bet , R van Westrhenen , M van Weelden
Tijdschrift voor psychiatrie 61 ( 10) 678 -680
2019
Pharmacogenetics in daily practice
R H N van Schaik , T van Gelder
Nederlands Tijdschrift voor Geneeskunde 164
2
2020
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice.
E J F Houwink , R H N van Schaik , W J G Hoogendijk , P M Bet
Frontiers in Pharmacology 12 640032
2021
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNA.
M Oellerich , M Neumaier , S Galbiati , M Del Re
Clinica Chimica Acta
2021
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
M L Becker , L E Visser , R H N van Schaik , A Hofman
Pharmacogenomics Journal 9 ( 4) 242 -247
165
2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients
P W Schenk , M van Vliet , R A A Mathot , T van Gelder
Pharmacogenomics Journal 10 ( 3) 219 -225
33
2010
Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
M L Becker , L L F S Elens , L E Visser , A Hofman
Pharmacogenomics Journal 13 ( 3) 251 -256
25
2013
Clinical validity of new genetic biomarkers of irinotecan neutropenia: An independent replication study
D J Crona , J Ramirez , W Qiao , A-J de Graan
Pharmacogenomics Journal 16 ( 1) 54 -59
24
2016
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
A J M Nieuweboer , M Smid , A-J M de Graan , S Elbouazzaoui
Pharmacogenomics Journal 16 ( 6) 519 -524
14
2016
Clinical Impact of New Prostate-Specific Antigen WHO Standardization on Biopsy Rates and Cancer Detection
F H Jansen , M Roobol , C H Bangma , R H N van Schaik
Clinical Chemistry 54 ( 12) 1999 -2006
24
2008
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
R H N van Schaik , C D J Wierikx , M A Timmerman , M H Oomen
British Journal of Cancer 82 ( 1) 112 -117
28
2000
The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer
L A Lammers , R H J Mathijssen , T van Gelder , M J Bijl
British Journal of Cancer 103 ( 6) 765 -771
51
2010
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)
M Joerger , R H N van Schaik , M L Becker , S Hayoz
Prostate Cancer and Prostatic Diseases 18 ( 2) 167 -172
11
2015
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients
P W Schenk , M A C van Fessem , S Verploegh-Van Rij , R A A Mathot
Molecular Psychiatry 13 ( 6) 597 -605
40
2008
Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.
R van der Pas , J H M van Esch , C de Bruin , A H J Danser
European Journal of Endocrinology 170 ( 2) 181 -191
11
2014
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
R H N van Schaik , M van Agteren , J W de Fijter , A Hartmann
Clinical Pharmacology & Therapeutics 86 ( 3) 319 -327
101
2009
Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662
M H M Diekstra , H J Klümpen , M P J K Lolkema , H Yu
Clinical Pharmacology & Therapeutics 96 ( 1) 81 -89
81
2014